Navigation Links
DFG welcomes decision on stem cell research by German parliament
Date:4/23/2008

This release is available in German.

The President of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Professor Matthias Kleiner, commented on the decision by the German Federal Parliament on the Stem Cell Act:

The Deutsche Forschungsgemeinschaft is pleased and grateful for the decision taken by Parliament. We are especially grateful to those members of Parliament who contributed towards the critical debate of the issue.

The decision taken to move the qualifying date for importing human embryonic stem cell lines is a good and important step forwards for German science and for German stem cell researchers. They will take advantage of the new possibilities with a strong sense of responsibility and according to their strict ethical principles.

First and foremost, we are very glad that the threat of legal sanctions that has existed up to now has been lifted. This was a particularly serious deterrent for young researchers wanting to go abroad.

All in all, the debate on the amendment of the Stem Cell Act is another good example of constructive dialogue between the scientific community and politics. The outcome of todays debate is also firm evidence of the confidence in the scientific community and its ability to argue its case.


'/>"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1

Related biology news :

1. Unconscious decisions in the brain
2. Arctic climate models playing key role in polar bear decision
3. To save or savor? Its decision time for Atlantic bluefin tuna
4. More comprehensive analysis of Klamath River basin needed to aid decision makers
5. Decisions on the second round of the Excellence Initiative announced
6. Cilia: small organelles, big decisions
7. American College of Medical Genetics responds to new FDA labeling decision for warfarin
8. McMaster University engineering professor receives Humboldt Research Award
9. Purdue researchers propose way to incorporate deforestation into climate change treaty
10. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
11. Research identifies first method for testing, assessing drug treatments for Chagas disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
Breaking Biology Technology: